PR Newswire BiotechOriginal article
Imbed Biosciences' DualGuard™ Silver-Gallium Matrix Safety Study Now Registered on ClinicalTrials.gov
Trial StartDualGuard™ Silver-Gallium MatrixPositive
AI Analysis
Summary
Imbed Biosciences announced the clinical trial registration (NCT07695688) for its DualGuard Silver-Gallium Matrix safety study, designed to address biofilm challenges in wound care applications.
Clinical Trial Data
NCT ID
Importance:3/10
Sentiment:
0.30
clinical trialsafety studyantimicrobialwound carebiofilmSAMatrix platform
Read the original article
Published by PR Newswire Biotech on October 1, 2026 1:54 PM
